SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-010589
Filing Date
2013-11-15
Accepted
2013-11-15 16:12:09
Documents
5
Period of Report
2013-12-19
Effectiveness Date
2013-11-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2217416zdef14a.htm DEF 14A 674225
2 G243072BGI001.GIF g243072bgi001.gif GRAPHIC 48300
3 G243072BGI002.GIF g243072bgi002.gif GRAPHIC 49222
4 G367710.JPG g367710.jpg GRAPHIC 8583
5 G360926.JPG g360926.jpg GRAPHIC 107598
  Complete submission text file 0001047469-13-010589.txt   970412
Mailing Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130
Business Address 12651 HIGH BLUFF DRIVE SUITE 230 SAN DIEGO CA 92130 858-436-3900
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35119 | Film No.: 131224086
SIC: 2834 Pharmaceutical Preparations